menu
    • menu

    Company profile for Avalyn Pharma

    NEW Drugs in Dev: 3
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. Our lead asset is inhaled pirfenidone (AP01) for the treatment of IPF. With offices in Seattle and San Diego, Avalyn's experienced clinical and inhaled product development team is rapidly advancing AP01 for the treatment of IPF and additional pipeline candidate...
    Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. Our lead asset is inhaled pirfenidone (AP01) for the treatment of IPF. With offices in Seattle and San Diego, Avalyn's experienced clinical and inhaled product development team is rapidly advancing AP01 for the treatment of IPF and additional pipeline candidates for IPF and other severe respiratory diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Avalyn PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    701 Pike Street Suite 1500 Seattle, WA 98101
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.avalynpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    MAGHREB Pharma Expo

    MAGHREB Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    MAGHREB Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pulmonary Fibrosis Biotech Avalyn Pharma Files For IPO
    Pulmonary Fibrosis Biotech Avalyn Pharma Files For IPO

    09 Apr 2026

    // ENDPOINTS

    https://endpoints.news/pulmonary-fibrosis-biotech-avalyn-pharma-files-for-ipo/

    ENDPOINTS
    09 Apr 2026
    Share Share
    Avalyn Plans IPO To Fund Ph. 3 Trials Of Inhaled Lung Drugs
    Avalyn Plans IPO To Fund Ph. 3 Trials Of Inhaled Lung Drugs

    09 Apr 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/avalyn-plans-ipo-fund-phase-3-trials-inhaled-versions-approved-respiratory-drugs

    FIERCE BIOTECH
    09 Apr 2026
    Share Share
    Avalyn Appoints Jon Congleton To Board Of Directors
    Avalyn Appoints Jon Congleton To Board Of Directors

    06 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/06/3268393/0/en/Avalyn-Appoints-Jon-Congleton-Seasoned-Biopharmaceutical-Executive-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    06 Apr 2026
    Share Share
    Avalyn Shows AP01 Improves IPF Lung Function And QoL
    Avalyn Shows AP01 Improves IPF Lung Function And QoL

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262138/0/en/Avalyn-Announces-Publication-Demonstrating-Correlation-Between-Imaging-Improved-Lung-Function-and-Quality-of-Life-with-AP01-in-Patients-with-Idiopathic-Pulmonary-Fibrosis.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Avalyn Initiates AURA Ph2 Trial For Inhaled Nintedanib
    Avalyn Initiates AURA Ph2 Trial For Inhaled Nintedanib

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260821/0/en/Avalyn-Announces-First-Patient-Dosed-in-AURA-Phase-2-Clinical-Trial-Evaluating-AP02-Inhaled-Nintedanib-for-the-Treatment-of-Idiopathic-Pulmonary-Fibrosis.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    Avalyn Appoints Kate Haviland To Board Of Directors
    Avalyn Appoints Kate Haviland To Board Of Directors

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250077/0/en/Avalyn-Appoints-Biopharmaceutical-Industry-Leader-Kate-Haviland-to-Board-of-Directors.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search